Anti-EGFR domain III抗體 | 貨號Ab00723-10.0

| 代理廠牌: | ![]() |
| 原廠連結: | |
| 相關下載: |
Fc Silent™ Antibodies: Turning down the background noise 只要訊號不要雜訊 (Engineered Fc Domain)
Absoluted Antibody 提供一系列抗體商品,其中Fc Silent™ Antibodies系列;能有效降低非特異性Fc結合。Fc Silent™技術,為應用生物工程技術,將Fc receptors (FcγR, FcR)點突變,進而中止抗體與ADCC的功能;有效降低Fc所造成的背景訊號。Fc Silent™抗體應用於免疫細胞時flow cytometry、immunohistochemistry (IHC)資料顯示,有效降低非特異性之Fc結合,所造成的背景值。(訂購抗體前,請確認選擇抗體是否有Fc Silent™修飾標誌)
產品介紹 Anti-EGFR domain III抗體 | 貨號Ab00723-10.0
Ab00723-10.0 Anti-EGFR domain III [h-R3 (Nimotuzumab)]
Description: Recombinant monoclonal antibody to EGFR domain III. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the therapeutic antibody h-R3 (Nimotuzumab).
Species and Isotype: Human IgG1, kappa
Clone Number: h-R3 (Nimotuzumab)
UniProt Accession Number of Target Protein:
Published Application(s): block; FC; IHC
Published Species Reactivity: human
Immunogen: This antibody we generated by humanisation of the murine antibody R3, raised against EGFR purified from placenta membranes and A431 tumors.
Specificity: Binds to human EGFR domain III at a site distinct from antibody 7A7 (Ab00134) (Talavera et al. 2011)
Application Notes: This antibody binds to human EGFR and inhibits EGF-dependent clonogenic growth of NRK cells and completely blocks EGF stimulated autophosphorylation of the receptor (Fernandez 1992)
